Benitec Biopharma (BNTC) Total Liabilities (2019 - 2025)

Benitec Biopharma (BNTC) has 7 years of Total Liabilities data on file, last reported at $3.3 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities changed N/A year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (changed N/A YoY), and the FY2025 full-year result was $2.3 million, down 53.71% from the prior year.
• Total Liabilities rose to $3.3 million in Q4 2025, from $2.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $7.6 million in Q1 2025 to a low of $1.4 million in Q2 2021.
• A 5-year average of $3.6 million and a median of $3.3 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 258.29% in 2021 and plunged 53.71% in 2025, its largest moves.
• Tracing BNTC's Total Liabilities over 5 years: stood at $3.2 million in 2021, then slipped by 8.4% to $2.9 million in 2022, then soared by 102.1% to $5.9 million in 2023, then fell by 21.91% to $4.6 million in 2024, then slipped by 27.73% to $3.3 million in 2025.
• Business Quant data shows BNTC's Total Liabilities at $3.3 million in Q4 2025, $2.4 million in Q3 2025, and $2.3 million in Q2 2025.